Annette Juul Vangsted

Annette Juul Vangsted serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical specialization is in Internal Medicine with a focus on Hematology, specifically multiple myeloma. Based at Blegdamsvej 9 in Copenhagen, she maintains an active research profile with 67 documented research outputs and extensive collaborations across Nordic countries and internationally.

Dr. Vangsted's research primarily centers on multiple myeloma, with particular emphasis on genetic predisposition, treatment outcomes, epidemiological patterns, and bone disease management. Her work bridges clinical practice with genetic research, examining how genetic variants influence disease risk and progression. She investigates geographical variations in myeloma incidence and outcomes, as well as novel treatment approaches for elderly patients and those with specific genetic profiles.

Analysis of her recent publications reveals a clear focus on multiple myeloma across several dimensions: genetic susceptibility (including large genome-wide association studies), treatment efficacy (particularly regarding bone disease management), epidemiological patterns across Nordic countries, and specialized care for elderly populations. Her collaborative approach is evident through numerous multi-center studies involving Nordic Myeloma Study Group and international research teams.

Dr. Vangsted actively participates in clinical research through the Nordic Myeloma Study Group, contributing to registry studies and clinical trials that inform treatment guidelines for multiple myeloma. Her work has significant implications for understanding disease mechanisms and improving patient outcomes, particularly in the areas of genetic risk assessment and personalized treatment approaches.

She maintains strong research collaborations across Denmark, Sweden, and international institutions, with particular focus on hematological malignancies. Her laboratory and clinical research team works within the Department of Clinical Medicine's hematology division, focusing on translational research that directly impacts clinical practice for myeloma patients.